Development of the ParaOesophageal hernia SympTom (POST) tool.


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
15 07 2022
Historique:
received: 29 12 2021
revised: 28 03 2022
accepted: 14 04 2022
pubmed: 1 6 2022
medline: 22 7 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

The aim of this study was to develop a symptom severity instrument (ParaOesophageal hernia SympTom (POST) tool) specific to para-oesophageal hernia (POH). The POST tool was developed in four stages. The first was establishment of a Steering Committee. In the second stage, items were generated through a systematic review and online scoping survey of international experts. In the third stage, a three-round modified Delphi consensus process was conducted with a group of international experts who were asked to rate the importance of candidate items. An a priori threshold for inclusion was set at 80 per cent. The modified Delphi process culminated in a consensus meeting to develop the first iteration of the tool. In the final stage, two international patient workshops were held to assess the content validity and acceptability of the POST tool. The systematic review and scoping survey generated 64 symptoms, refined to 20 for inclusion in the modified Delphi consensus process. Twenty-six global experts participated in the Delphi consensus process. Five symptoms reached consensus across two rounds: difficulty getting solid foods down, chest pain after meals, difficulty getting liquids down, shortness of breath only after meals, and an early feeling of fullness after eating. The subsequent patient workshops deemed these five symptoms to be relevant and suggested that reflux should be included; these were taken forward to create the final POST tool. The POST tool is the first instrument designed to capture POH-specific symptoms. It will allow clinicians to standardize reporting of symptoms of POH and evaluate the response to surgical intervention.

Sections du résumé

BACKGROUND
The aim of this study was to develop a symptom severity instrument (ParaOesophageal hernia SympTom (POST) tool) specific to para-oesophageal hernia (POH).
METHODS
The POST tool was developed in four stages. The first was establishment of a Steering Committee. In the second stage, items were generated through a systematic review and online scoping survey of international experts. In the third stage, a three-round modified Delphi consensus process was conducted with a group of international experts who were asked to rate the importance of candidate items. An a priori threshold for inclusion was set at 80 per cent. The modified Delphi process culminated in a consensus meeting to develop the first iteration of the tool. In the final stage, two international patient workshops were held to assess the content validity and acceptability of the POST tool.
RESULTS
The systematic review and scoping survey generated 64 symptoms, refined to 20 for inclusion in the modified Delphi consensus process. Twenty-six global experts participated in the Delphi consensus process. Five symptoms reached consensus across two rounds: difficulty getting solid foods down, chest pain after meals, difficulty getting liquids down, shortness of breath only after meals, and an early feeling of fullness after eating. The subsequent patient workshops deemed these five symptoms to be relevant and suggested that reflux should be included; these were taken forward to create the final POST tool.
CONCLUSION
The POST tool is the first instrument designed to capture POH-specific symptoms. It will allow clinicians to standardize reporting of symptoms of POH and evaluate the response to surgical intervention.

Identifiants

pubmed: 35640625
pii: 6595434
doi: 10.1093/bjs/znac139
pmc: PMC10364681
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

727-732

Investigateurs

R Aye (R)
B Louie (B)
R Baigrie (R)
L Bonavina (L)
G Darling (G)
P M Fisichella (PM)
S Jaume-Bottcher (S)
J C Lipham (JC)
W S Melvin (WS)
K Nason (K)
B Oelschlager (B)
F Puccetti (F)
R Rosati (R)
J S Roth (JS)
P Siersma (P)
B Smithers (B)
N Soper (N)
S Thompson (S)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Am J Surg. 2017 Oct;214(4):651-656
pubmed: 28826953
Trials. 2016 Sep 13;17(1):449
pubmed: 27618914
Dis Esophagus. 2013 Jul;26(5):538-43
pubmed: 22642514
Int J Nurs Pract. 2012 Apr;18(2):188-94
pubmed: 22435983
Respir Med Case Rep. 2017 Aug 12;22:212-214
pubmed: 28879080
BMJ Open Gastroenterol. 2021 Mar;8(1):
pubmed: 33731384
JSLS. 2019 Jan-Mar;23(1):
pubmed: 30675094
J Thorac Cardiovasc Surg. 2010 Feb;139(2):395-404, 404.e1
pubmed: 20004917
Trials. 2017 Jun 20;18(Suppl 3):280
pubmed: 28681707
Dis Esophagus. 2007;20(2):130-4
pubmed: 17439596
J Gastrointest Surg. 2011 Mar;15(3):389-96
pubmed: 21246416
Dis Esophagus. 2021 Jul 12;34(7):
pubmed: 33434921
J Gastrointest Surg. 2020 Apr;24(4):749-755
pubmed: 31012041

Auteurs

Aiysha Puri (A)

Department of Surgery and Cancer, Imperial College London, London, UK.

Nikhil M Patel (NM)

Department of Surgery and Cancer, Imperial College London, London, UK.

Viknesh Sounderajah (V)

Department of Surgery and Cancer, Imperial College London, London, UK.

Lorenzo Ferri (L)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, Quebec, Canada.

Ewen A Griffiths (EA)

Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham, UK.
Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Donald Low (D)

Department of Thoracic Surgery and Thoracic Oncology, Virginia Mason Medical Centre, Seattle, Washington, USA.

Nick Maynard (N)

Oxford Oesophagogastric Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Carmen Mueller (C)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, Quebec, Canada.

Manuel Pera (M)

Department of Surgery, University Hospital del Mar, Barcelona, Spain.
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

Mark I van Berge Henegouwen (MI)

Department of Surgery, Amsterdam University Medical Centres, Cancer Centre Amsterdam, Amsterdam, the Netherlands.

David I Watson (DI)

Flinders University, Discipline of Surgery, Flinders Medical Centre, Adelaide, South Australia, Australia.
College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.

Giovanni Zaninotto (G)

Department of Surgery and Cancer, Imperial College London, London, UK.

George B Hanna (GB)

Department of Surgery and Cancer, Imperial College London, London, UK.

Sheraz R Markar (SR)

Department of Surgery and Cancer, Imperial College London, London, UK.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Nuffield Department of Surgery, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH